What is Xenon Pharmaceuticals's PP&E (net)?

Xenon Pharmaceuticals (XENE) reported PP&E (net) of $8.29M in Q1 2026.

How has Xenon Pharmaceuticals's PP&E (net) changed year-over-year?

Xenon Pharmaceuticals's PP&E (net) decreased by 14.5% year-over-year, from $9.7M to $8.29M.

What is the long-term trend for Xenon Pharmaceuticals's PP&E (net)?

Over 5 years (2020 to 2025), Xenon Pharmaceuticals's PP&E (net) has grown at a 19.7% compound annual growth rate (CAGR), from $3.55M to $8.72M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Xenon Pharmaceuticals XENE PP&E (Net)

PP&E (Net) at other companies

Eli LillyLLY

$26.54B+43.7%

Johnson & JohnsonJNJ

$23.27B+11.5%

Jazz PharmaceuticalsJAZZ

$203.1M+13.5%

Axsome TherapeuticsAXSM

$567K-26.6%

Praxis Precision Medicines, Inc.PRAX

$170K-31.2%

Neurocrine BiosciencesNBIX

$90.9M+4.5%

Other financials

Income statement

See full

Revenue--100%

Operating income-$112.3M-54.4%

Net income-$102.3M-57.3%

EPS (diluted)-$1.17-41.0%

Balance sheet

See full

Cash & equivalents$545.9M+368%

Total debt$7.5M-13.6%

Total equity$1.3B+90.0%

Total assets$1.4B+86.6%

Cash flow

See full

Operating cash flow-$88.9M-44.2%

CapEx$133.0K+209%

Free cash flow-$89.0M-44.3%

Valuation

See full

Market cap$5.11B+116%

Profitability

See full

Operating margin-4,974.3%—

Net margin-4,612.1%—

FCF margin-3,732.2%—

Returns & leverage

See full

Return on equity-37.5%+8.7pp

Debt / equity0×0.0×

Current ratio27.8×+10.1×

Where this comes from

Reported directly by Xenon Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Xenon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xenon Pharmaceuticals's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Xenon Pharmaceuticals's PP&E (net)?: Xenon Pharmaceuticals (XENE) reported PP&E (net) of $8.29M in Q1 2026.
How has Xenon Pharmaceuticals's PP&E (net) changed year-over-year?: Xenon Pharmaceuticals's PP&E (net) decreased by 14.5% year-over-year, from $9.7M to $8.29M.
What is the long-term trend for Xenon Pharmaceuticals's PP&E (net)?: Over 5 years (2020 to 2025), Xenon Pharmaceuticals's PP&E (net) has grown at a 19.7% compound annual growth rate (CAGR), from $3.55M to $8.72M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.